09.01.2013
- Switzerland's biggest health insurer CSS is supporting a young woman in her claim against Bayer, as the fall-out from alleged side effects of the German drugmaker's contraceptive...
09.01.2013
- BioMarin Pharmaceutical, which makes high-priced drugs used to treat rare diseases, would not consider a buy-out offer for even a 25-30% premium, according to the company's chief...
09.01.2013
- Amgen, the world's largest biotechnology company, on Tuesday lowered its outlook for 2012 earnings per share by 10 cents, citing a delay in the impact of a U.S. tax credit for...
08.01.2013
- Fuel additives maker Innospec is looking to buy an oilfield specialty company for less than $300 million by the end of the first quarter, its top executive said. "We are combing...
08.01.2013
- British drugmaker Shire has agreed to buy Lotus Tissue Repair, a U.S. biotechnology company developing the first treatment for a rare genetic disorder that causes extremely fragile...
08.01.2013
- Monsanto, the world's largest seed company, raised its earnings outlook for fiscal 2013 on Tuesday and delivered surprisingly strong first-quarter results, citing growth in Latin...
08.01.2013
- China will cut prices of about 400 drugs for respiratory diseases, fever and pain by up to 20% from February, in a move to make medicines, including some products from Pfizer...
08.01.2013
- AMRI announced today that Richard A. Saffee has been promoted to the newly created role of Vice President and General Manager of Large Scale Manufacturing, effective immediately...
08.01.2013
- Sartorius Stedim Biotech, a pharmaceutical and biotech supplier, today announced a substantial expansion of its product rray in the cell culture range. The company signed a...
08.01.2013
- Following a detailed appraisal, the Cologne district authority has granted Bayer MaterialScience the permit to build and operate the new high-tech facility for the production of...
